info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142499 |
| CAS No | NA |
| Mol.F. | C8H4N8O3S |
| Mol.Wt. | 292.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142500 |
| CAS No | NA |
| Mol.F. | C5H3N5OS |
| Mol.Wt. | 181.17 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142501 |
| CAS No | NA |
| Mol.F. | C3H3N5O3 |
| Mol.Wt. | 157.09 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142502 |
| CAS No | NA |
| Mol.F. | C3HClN4O3 |
| Mol.Wt. | 176.52 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142503 |
| CAS No | NA |
| Mol.F. | C3H2N4O3S |
| Mol.Wt. | 174.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142504 |
| CAS No | NA |
| Mol.F. | C3HN4O4 |
| Mol.Wt. | 157.07 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142505 |
| CAS No | NA |
| Mol.F. | C25H29N3O5 |
| Mol.Wt. | 451.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142506 |
| CAS No | NA |
| Mol.F. | C11H10N2O3 |
| Mol.Wt. | 218.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142507 |
| CAS No | NA |
| Mol.F. | C10H10N2O2 |
| Mol.Wt. | 190.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142508 |
| CAS No | 3039566-57-6 |
| Mol.F. | C15H20N2O4 |
| Mol.Wt. | 292.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142509 |
| CAS No | NA |
| Mol.F. | C26H31N3O5 |
| Mol.Wt. | 465.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142510 |
| CAS No | NA |
| Mol.F. | C14H189N2O4 |
| Mol.Wt. | 278.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142511 |
| CAS No | NA |
| Mol.F. | C23H25N3O5 |
| Mol.Wt. | 423.47 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142512 |
| CAS No | NA |
| Mol.F. | C13H20N4O2S |
| Mol.Wt. | 296.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142513 |
| CAS No | NA |
| Mol.F. | C20H33N3O6 |
| Mol.Wt. | 411.50 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142514 |
| CAS No | NA |
| Mol.F. | C20H33N3O6 |
| Mol.Wt. | 411.5 g/mol |
| INV STATUS | In Stock |
